We are live on ! Find out more
7IH

72 Investment Holdings Portfolio holdings

AUM $49.6M
1-Year Est. Return 684.72%
This Fund
S&P 500
This Quarter Est. Return
-2.41%
1 Year Est. Return
+684.72%
3 Year Est. Return
+1,518.31%
5 Year Est. Return
+6,127.68%
10 Year Est. Return
AUM
$211M
AUM Growth
-$6.35M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXDX
1
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$198M 93.93%
1,848,024
TRDA icon
2
Entrada Therapeutics
TRDA
$264M
$7.38M 3.5%
509,023
CRBU icon
3
Caribou Biosciences
CRBU
$145M
$2.52M 1.19%
474,067
OMGA
4
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$2.13M 1.01%
352,941
PRAX icon
5
Praxis Precision Medicines
PRAX
$8.58B
$800K 0.38%
65,933

Similar funds

72 Investment Holdings's Q1 2023 Portfolio in Review

As of Q1 2023, 72 Investment Holdings held 5 positions worth $211M, down 2.9% from $218M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. 72 Investment Holdings opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • 72 Investment Holdings's ten largest holdings make up 100% of its $211M portfolio in Q1 2023.
  • 72 Investment Holdings opened 0 new positions and closed 0 in Q1 2023.
  • 72 Investment Holdings's portfolio value fell 2.9% quarter-over-quarter to $211M.

Based on 72 Investment Holdings's 13F filing for Q1 2023, filed 15 May 2023.